ADAP

Lifshitz Law PLLC Announces Investigations of SGEN, PRVB, KBAL, and ADAP

Retrieved on: 
Sunday, March 19, 2023
Therapy, ADAP, HNI, Telephone, PLLC, Pfizer, Sale, Advertising, HNI Corporation, KBAL, Hewlett, Online shopping

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash.

Key Points: 
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash.
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of PRVB to Sanofi S.A. for $25.00 per share in cash.
  • Lifshitz L aw PLLC announces investigation into possible breach of fiduciary duties in connection with the merger of ADAP and TCR² Therapeutics, Inc.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – ADAP, LBC, SAL, BRBW

Retrieved on: 
Wednesday, March 15, 2023
Acquisition, Monteverde, Therapy, Washington Federal, SAL, NBT Bank, LBC, Empire, ADAP, OTC, NBT, Security (finance)

Under the terms of the agreement, ADAP shareholders are expected to own approximately 75% of the combined company.

Key Points: 
  • Under the terms of the agreement, ADAP shareholders are expected to own approximately 75% of the combined company.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, LBC shareholders will receive 0.3353 shares of Washington per share they own.
  • Under the terms of the merger, SAL shareholders will receive 0.745 shares of NBT per share they own.

Lifshitz Law PLLC Announces Investigations of DSEY, KBAL, ADAP, and TCRR

Retrieved on: 
Thursday, March 9, 2023
Therapy, Advertising, PLLC, HNI, Telephone, ADAP, HNI Corporation, Hewlett, Sale, KBAL, Online shopping, Security (finance), Solenis

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of DSEY to Solenis for $8.40 per share in cash.

Key Points: 
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of DSEY to Solenis for $8.40 per share in cash.
  • Lifshitz L aw PLLC announces investigation into possible breach of fiduciary duties in connection with the merger of ADAP and TCR² Therapeutics, Inc.
  • Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of TCRR and Adaptimmune Therapeutics PLC.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – LBC, ADAP, BRBW, SAL

Retrieved on: 
Wednesday, March 8, 2023
Therapy, NBT Bank, NBT, Washington Federal, Acquisition, ADAP, Empire, OTC, LBC, Monteverde, Security (finance)

Under the terms of the agreement, LBC shareholders will receive 0.3353 shares of Washington per share they own.

Key Points: 
  • Under the terms of the agreement, LBC shareholders will receive 0.3353 shares of Washington per share they own.
  • Adaptimmune Therapeutics plc (NASDAQ: ADAP ), relating to its proposed merger with TCR² Therapeutics Inc.
  • Salisbury Bancorp, Inc. (Nasdaq: SAL ), relating to its proposed merger NBT Bancorp, Inc.
  • Under the terms of the merger, SAL shareholders will receive 0.745 shares of NBT per share they own.

Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors

Retrieved on: 
Monday, March 6, 2023
Ovarian cancer, CD70, Mesothelin, MPM, ADAP, TCR, Specialization, IND, Webcast, Engineering, Platinum, Ovary, Neoplasm, Growth, Mesothelioma, Synovial sarcoma, TNBC, Therapy, Nivolumab, JAMA Otolaryngology–Head & Neck Surgery, PRAME, Patient, TD, Truc, Simple squamous epithelium, Carcinoma, Survival, Cancer, EST, SPEAR, BLA, Otorhinolaryngology, Overalls, PDUFA, Bank, Holding company, Pharmaceutical industry, Vaccine, Fine chemical, Birth control, Cryptocurrency, EU

Adrian Rawcliffe, Adaptimmune’s Chief Executive Officer: “This strategic combination takes two technologically and culturally aligned companies at the forefront of their fields and combines them to create a preeminent cell therapy company for solid tumors.

Key Points: 
  • Adrian Rawcliffe, Adaptimmune’s Chief Executive Officer: “This strategic combination takes two technologically and culturally aligned companies at the forefront of their fields and combines them to create a preeminent cell therapy company for solid tumors.
  • The combined company will drive forward its pipeline of cell therapies aimed at treating multiple cancers with high unmet medical needs.
  • Focus and specialization are critical in the cell therapy space and we believe the combined company has the technologies necessary to succeed.
  • The combined company has a team of leading cell therapy experts led by Adrian Rawcliffe, the CEO of Adaptimmune.

TCR² THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TCR² Therapeutics Inc. - TCRR

Retrieved on: 
Wednesday, March 8, 2023
Class Action Lawsuit, Professional Services, Legal, Therapy, KSF, ADAP, Sale

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TCR² Therapeutics Inc. (NasdaqGS: TCRR) to Adaptimmune Therapeutics plc (NasdaqGS: ADAP).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TCR² Therapeutics Inc. (NasdaqGS: TCRR) to Adaptimmune Therapeutics plc (NasdaqGS: ADAP).
  • Under the terms of the proposed transaction, shareholders of TCR² will receive 1.5117 ADS of Adaptimmune for each share of TCR² that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

ADAP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Adaptimmune Therapeutics plc Is Fair to Shareholders

Retrieved on: 
Monday, March 6, 2023
Class Action Lawsuit, Professional Services, Legal, Therapy, Fraud, ADAP, Advertising, Security (finance)

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Adaptimmune Therapeutics plc (NASDAQ: ADAP) and TCR² Therapeutics Inc. is fair to Adaptimmune shareholders.

Key Points: 
  • Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Adaptimmune Therapeutics plc (NASDAQ: ADAP) and TCR² Therapeutics Inc. is fair to Adaptimmune shareholders.
  • Following the closing of the transaction, Adaptimmune shareholders will own approximately 75% of the combined company.
  • On behalf of Adaptimmune shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

MISTR EXPANDS TELEHEALTH PLATFORM TO INCLUDE LONG-TERM HIV CARE

Retrieved on: 
Thursday, December 1, 2022
Viral load, Telehealth, Human, ADAP, Pharmacist, Insurance, Patient, AIDS Drug Assistance Programs, Andrew Kohut, HIV, Infection, PAP, ART, Pharmaceutical industry, Health insurance

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- MISTR, the telehealth platform built to provide free and discreet online access to pre-exposure prophylaxis (PrEP), has expanded its offering to include long-term HIV treatment. Through MISTR, people who test positive for HIV will now be able to connect virtually with a physician and build a long-term care plan with no out-of-pocket costs or in-office doctors' appointments. MISTR's free online PrEP and HIV services are available in all 50 states, D.C. and Puerto Rico.

Key Points: 
  • Through MISTR, people who test positive for HIV will now be able to connect virtually with a physician and build a long-term care plan with no out-of-pocket costs or in-office doctors' appointments.
  • MISTR is a company designed specifically to serve gay and bisexual men, a population disproportionately impacted by HIV.
  • With the introduction of long-term HIV care, MISTR now offers two options for reducing the spread of the virus: PrEP and antiretroviral therapy (ART).
  • MISTR is a telemedicine platform offering easy online access to pre-exposure prophylaxis (PrEP) and long-term HIV care in all 50 states, D.C. and Puerto Rico.

ADAP Advocacy Association Spearheads National Campaign to Protect Ryan White HIV/AIDS Program

Retrieved on: 
Monday, August 15, 2022
HIV/AIDS, Association, Multimedia, Public health, House Committee, White, AIDS Drug Assistance Programs, HELP, Congress, Ryan, Commerce, Government, Labour, United States Senate Committee on Commerce, Science, and Transportation, Patient, Education, Program, Central Laborers' Pension Fund v. Heinz, Energy, Awareness, ADAP, United States Senate Committee on Health, Education, Labor and Pensions, AIDS, HIV, Ranking, Person, Health insurance, Pharmaceutical industry, Health

WASHINGTON, Aug. 15, 2022 /PRNewswire/ -- The ADAP Advocacy Association today submitted a sign-on letter to Congress expressing the HIV Community's collective concerns over the Ryan White PrEP Availability Act (S.4395). The sign-on letter – which was endorsed by nearly 100 national, state, and local organizations – is part of a national campaign to protect the Ryan White HIV/AIDS Program (RWHAP), namely opposing efforts to raid the program to fund pre-exposure prophylaxis.

Key Points: 
  • WASHINGTON, Aug. 15, 2022 /PRNewswire/ -- The ADAP Advocacy Association today submitted a sign-on letter to Congress expressing the HIV Community's collective concerns over the Ryan White PrEP Availability Act (S.4395).
  • The sign-on letter which was endorsed by nearly 100 national, state, and local organizations is part of a national campaign to protect the Ryan White HIV/AIDS Program (RWHAP), namely opposing efforts to raid the program to fund pre-exposure prophylaxis.
  • To learn more about the ADAP Advocacy Association , AIDS Drug Assistance Programs, or S.4395, please email [email protected].
  • About the ADAP Advocacy Association: The ADAP Advocacy Association mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improves access to care for persons living with HIV/AIDS.

Supernovae Could Explain Cosmic Dust in the Early Universe

Retrieved on: 
Monday, June 13, 2022
Universe, Life, SETI, ISM, National, SOFIA, Research, SETI Institute, Knowledge, Herschel, SNR, Spitzer, National Science Foundation, Planet, Field line, National academy, Intelligence, Stratospheric Observatory for Infrared Astronomy, Cosmic dust, Government, NASA, Machine learning, Silicate, Unitary state, Technology, Universities Space Research Association, Survival rate, Noise, Prevalence, Industry, Dust, USRA, Engineering, History, American Astronomical Society 215th meeting, Element, ADAP, Carbon, Cassiopeia A, Telescope, Cement

and PASADENA, Calif., June 13, 2022 /PRNewswire/ -- New research from the Stratospheric Observatory for Infrared Astronomy (SOFIA) High-Resolution Airborne Wideband Camera Plus (HAWC+) provides evidence that the cosmic dust in the early universe was formed in supernovae.

Key Points: 
  • and PASADENA, Calif., June 13, 2022 /PRNewswire/ -- New research from the Stratospheric Observatory for Infrared Astronomy (SOFIA) High-Resolution Airborne Wideband Camera Plus (HAWC+) provides evidence that the cosmic dust in the early universe was formed in supernovae.
  • Though theoretical models have previously shown that dust formation in supernovae could explain the presence of dust in the early universe, whether there would be evidence of sufficient amounts of dust forming remained an open question.
  • For one, the fact that polarized dust emission comes from an SNR implies that supernovae produce a large mass of dust and were important dust sources in the early universe.
  • The large amount of dust from the polarized regions of the SNR shows that supernovae are major dust producers in the early universe.